Table: RaQualia Pharma - 9-MTH group results

RaQualia Pharma

14/11/2024 06:36

Nov 14 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2024        Sep 30, 2023     Dec 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             2.37                1.50             4.54     
                 (+58.4 pct)         (-21.5 pct)     (+138.5 pct) 
  Operating      loss 27 mln        loss 108 mln        313 mln   
  Recurring     loss 231 mln         loss 36 mln        290 mln   
  Net           loss 339 mln        loss 117 mln        236 mln   
  EPS          loss 15.71 yen       loss 5.45 yen      10.91 yen  
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T